Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions

## Example Bundle: IPS Example JP

id: gravitate-ips-jp
Composition status: final
Composition Type: Patient summary Document
Subject:
identifier: ips-jp
Name: IPS-JP Gravitate
active: true
gender: female
Birth Date: 1946-05-05

### Sections

#### Problem List

Condition: Malignant neoplasm of breast (254837009)
clinicalStatus: active
asserter: Dr. IPS-JP
Condition: Rheumatoid arthritis (69896004)
clinicalStatus: active
asserter: Dr. IPS-JP
onsetDateTime: 2015
Condition: Hypercholesterolemia (13644009)
clinicalStatus: active
onsetDateTime: 1993
Condition: Epilepsy (84757009)
clinicalStatus: active
onsetDateTime: 1993

#### Allergies and Intolerances

Allergy: (no-allergy-info)
clinicalStatus: active
verificationStatus: confirmed

#### Medication Summary

Medication: trastuzumab
status: active
Medication Detail:

- System http://iyaku.info/medicine/ Code: 4291447D2024 []

Dose Form: Powder and solvent for concentrate for solution for infusion
Ingredient: trastuzumab (http://fdasis.nlm.nih.gov#P188ANX8CK)
Route: Intravenous use
Medication: simvastatin
status: active
Medication Detail:

- System http://iyaku.info/medicine/ Code: 2189011F1262 []

- System https://www.who-umc.org/phpid Code: F92168108C432D63DACDD70444176BB3 [Lipcut Simvastatin 5 mg tablet]

Dose Form: Tablet
Ingredient: SIMVASTATIN (http://fdasis.nlm.nih.gov#AGG2FN16EV)
Route: Oral use
Medication: enbrel
status: active
Medication Detail:

- System https://www.who-umc.org/phpid Code: 0xF79CABF272B6A7EEF104DDDA44E82716 [Enbrel Etanercept 25 mg powder for solution for injection]

Dose Form: Powder and solution for solution for injection
Ingredient: ETANERCEPT (ENBREL) (http://fdasis.nlm.nih.gov#OP401G7OJC)
Route: Subcutaneous use
Medication: carbamazepine
status: active
Medication Detail:

- System http://iyaku.info/medicine/ Code: 1139002F1070 []

- System https://www.who-umc.org/phpid Code: 5C62673C79E096D37914D32A45AA8F4D [Tegretol Carbamazepine 200 mg tablets]

- System https://www.who-umc.org/phpid Code: FB9808F4FED210183F412F9998622287 [Tegretol Carbamazepine 200 mg tablets]

Dose Form: Tablet
Ingredient: CARBAMAZEPINE (http://fdasis.nlm.nih.gov#33CM23913M)
Route: Oral use